Literature DB >> 19996081

Intramedullary Sjögren syndrome.

S Chahin1, M D Garwood, E K St Louis, E Torage Shivapour, P M Kelkar, M A Granner.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19996081      PMCID： PMC2796455          DOI： 10.1212/WNL.0b013e3181c55ced

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  An autopsied case of Sjogren's syndrome with massive necrotic and demyelinating lesions of the cerebellar white matter.

Authors:  Hiroo Ichikawa; Kenji Ishihara; Ryuhachiro Fujimoto; Takayuki Katoh; Masanobu Arai; Mitsuru Kawamura; Imaharu Nakano
Journal:  J Neurol Sci       Date:  2004-10-15       Impact factor: 3.181

3.  NMO-IgG detected in CSF in seronegative neuromyelitis optica.

Authors:  E C Klawiter; E Alvarez; J Xu; A R Paciorkowski; L Zhu; B J Parks; A H Cross; R T Naismith
Journal:  Neurology       Date:  2009-03-24       Impact factor: 9.910

4.  A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases.

Authors:  S M Weiner; R Klein; P A Berg
Journal:  Rheumatol Int       Date:  2000       Impact factor: 2.631

5.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

Review 6.  Primary Sjögren's syndrome with severe central nervous system disease.

Authors:  R K Niemelä; M Hakala
Journal:  Semin Arthritis Rheum       Date:  1999-08       Impact factor: 5.532

7.  Primary Sjögrens syndrome presenting as neuromyelitis optica.

Authors:  Figen Gökçay; Neşe Celebisoy; Ahmet Gökçay; Yasemin Kabasakal; Gonca Oder
Journal:  Pediatr Neurol       Date:  2007-01       Impact factor: 3.372
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.